Название документа

Tablets coated are shown to Glentset at symptomatic treatment of allergic rhinitis, including year-round allergic rhinitis and urticaria.

Structure

Active ingredient: levocetirizine;

1 tablet supports a levotsetirizin of dihydrochloride of 5 mg;

Excipients: lactose, cellulose microcrystalline, silicon dioxide colloidal, magnesium stearate, Opadry white (Opadry Y 1-7000) of the titan dioxide (E 171), polyethyleneglycol, gipromelloza.

Contraindication

Hypersensitivity to a levotsetirizin or to any other component of this dosage form, or to any derivatives of piperazin.
Severe form of chronic kidney disease (clearance of creatinine <10 ml/min.).
Rare hereditary diseases of intolerance of a galactose, lactose intolerance or violation of digestion of glucose and galactose.

Route of administration Drug to appoint

by
to adults and children 6 years inside in a daily dose of 5 mg of 1 times a day are more senior. To take a pill irrespective of meal. It is necessary to swallow of a tablet entirely, washing down with a small amount of water.
to

Pregnant

Levotsetirizin is contraindicated to

Feature of application

during pregnancy.

Children

not to use Drug in the form of tablets to children up to 6 years as such dosage form does not allow to carry out necessary correction of the mode of dosing.

Drivers

Should abstain from control of motor transport or work with mechanisms for treatment.

Overdose

Symptoms of overdose can include drowsiness at adults and initial excitement and acrimony with the subsequent drowsiness at children.

Treatment. There is no specific antidote to a levotsetirizin. In case of symptoms of overdose the symptomatic and maintenance therapy is recommended. It is necessary to consider need gastric lavage through short time after use of medicine. The hemodialysis for removal of a levotsetirizin from an organism is not effective.

Side effects

from nervous system: drowsiness, headache, increased fatigue, weakness, adynamy, spasms, paresthesias, dizziness, syncope, tremor, dysgeusia.
from mentality: sleep disorder, excitement, hallucinations, depression, aggression, insomnia, suicide thoughts.
from heart: tachycardia, tachycardia.
from an organ of sight: disorder of vision, illegibility of sight.
from organs of hearing and balance: vertigo.
from a liver and biliary tract: hepatitis.
from kidneys and an urinary system: dysuria, ischuria.
from the immune system: hypersensitivity, including anaphylaxis.
from the respiratory system, bodies of a thorax and mediastinum: short wind.
from digestive tract: diarrhea, vomiting, a lock, dryness in a mouth, nausea, an abdominal pain.
from skin and hypodermic fabrics: Quincke's disease, steady medicamentous rashes, itch, rash, small tortoiseshell.
from a musculoskeletal system, connective tissue and bones: myalgia.

Interaction

Researches on levotsetirizin on interaction were not conducted.

Meal does not influence extent of absorption of medicine, but simultaneous consumption of food reduces absorption speed.

Storage conditions

to Store

in original packing at a temperature not above 25 °C.
to Store
out of children's reach.

Expiration date - 3 years.

Characteristics
Active ingredients	Levotsetirizin
Amount of active ingredient	5 mg
Applicant	Glenmark
Code of automatic telephone exchange	R06AE09 Levotsetirizin
Interaction with food	In time
Light sensitivity	Not sensitive
Market status	The branded generic
Origin	Chemical
Prescription status	Without prescription
Primary packing	blister
Producer	GLENMARK PHARMASYYUTIKALZ LTD
Quantity in packing	30 tablets (3 blisters on 10 pieces)
Release form	tablets for internal use
Route of administration	Oral
Sign	Import
Storage temperature	from 5 °C to 25 °C
Trade name	Glentset